Investment Rating - The investment rating for the company is "Buy-A" with a target price of 126.71 CNY per share, maintaining the rating [4][8]. Core Insights - The company is actively participating in national strategic projects, aligning with the "14th Five-Year Plan" and "15th Five-Year Plan" to drive breakthroughs in key technologies in integrated circuits, high-end instruments, and other critical areas [1]. - The high-end microscope business is expected to see a recovery in growth, with the proportion of high-end products exceeding 40% of total microscope sales [2]. - The company is diversifying its optical business, with semiconductor optics expected to contribute significantly to revenue growth [3]. Summary by Sections Business Development - The company is leading national major instrument projects, focusing on ultra-high resolution imaging technology and surgical navigation microscopes, which are expected to enhance its competitive edge [2]. - The high-end microscope segment is projected to recover in the second half of 2025, with a significant increase in high-end product orders [2]. Optical Business Diversification - Barcode scanning and machine vision businesses are growing steadily, with successful collaborations with major clients like Zebra and Honeywell [3]. - The automotive laser radar optical components have achieved mass production, with shipments nearing one million units in the first half of 2025 [3]. - The medical optical segment has seen substantial growth, driven by domestic substitution and increased overseas demand for medical imaging components [3]. Financial Projections - Revenue projections for 2025-2027 are 1.09 billion CNY, 1.40 billion CNY, and 1.78 billion CNY, respectively, with net profits of 270 million CNY, 367 million CNY, and 480 million CNY [8][10]. - The company is expected to maintain a strong competitive advantage in precision optical manufacturing, with continued growth in microscopes and semiconductor optics [8].

Core Insights - Yongxin Optical achieved a revenue of 674 million yuan in the first three quarters of 2025, representing a year-on-year growth of 3.59%, and a net profit attributable to shareholders of 151 million yuan, up 7.69% year-on-year [2] - The company attributed its steady growth in revenue and net profit to optimized product structure and meticulous cost control [2] - The medical optics segment saw significant revenue growth, particularly in high-end microscope sales, which now account for over 40% of the company's overall microscope sales [2] Financial Performance - Revenue for the first three quarters of 2025: 674 million yuan, a 3.59% increase year-on-year [2] - Net profit for the same period: 151 million yuan, a 7.69% increase year-on-year [2] - The company effectively controlled operational costs through product optimization and expense management [2] Product Development and Market Position - The sales proportion of medical optical products and high-end microscopes is expected to continue increasing due to ongoing product upgrades and accelerated domestic substitution [2] - The high-end microscope business is characterized by high technical and complexity barriers, maintaining a high gross margin and stable profit performance [2] - Yongxin Optical focuses on technological innovation, planning to continuously iterate superior products in the high-end microscope field and develop high-value core components in the medical optics sector [2] Industry Collaboration - Yongxin Optical is a key partner for companies like Hesai Technology and Tudatong Intelligent Technology in the LiDAR sector [3] - The company's products are widely used in high-growth markets such as mobile robots, delivery robots, cleaning robots, and lawn mowing robots [3] - Yongxin Optical has established close partnerships with leading companies in the robotics industry [3]

Group 1 - Yongxin Optical (SH 603297) announced on November 24 that its 8th Board of Directors held a meeting to review the proposal for establishing a "Company Public Opinion Management System" [1] - For the year 2024, Yongxin Optical's revenue composition is as follows: optical product manufacturing accounts for 97.53%, while other businesses account for 2.47% [1] - As of the report, Yongxin Optical has a market capitalization of 10.4 billion yuan [1] Group 2 - Dapeng Industrial's strategic placement has significantly benefited its insiders, with a subscription price of 9 yuan and a first-day listing price of 118 yuan, resulting in a paper profit of 24.92 million yuan for the controlling shareholder and his brother [1]

Core Points - Yongxin Optical convened its 14th meeting of the 8th Board of Directors on November 24, 2025, and unanimously approved the proposal for a public opinion management system aimed at establishing a systematic response framework to ensure stable operations and protect investors' rights [1][3][4] Meeting Compliance and Attendance - The board meeting was conducted in compliance with the Company Law and the company's articles of association, with a 100% attendance rate from the 9 directors [2] Public Opinion Management System Focus - The newly approved public opinion management system is designed to enhance risk prevention and investor protection, including establishing a rapid response mechanism, mitigating negative impacts on stock prices and business reputation, and strengthening investor relations [3][4] Voting Results - The proposal received unanimous support with 9 votes in favor, 0 against, and 0 abstentions, indicating strong consensus among the board members [4]

Group 1 - The core point of the article is the announcement by Yongxin Optical regarding the election of Mr. Xu Zuwei as the employee director of the company's eighth board of directors [2]

证券代码：603297 证券简称：永新光学 公告编号：2025-048 宁波永新光学股份有限公司 (二) 离任对公司的影响 公司董事会于近日收到董事薛志伟先生提交的董事辞任报告，薛志伟先生因 个人原因申请辞去公司第八届董事会董事职务。根据《中华人民共和国公司法》 （以下简称"《公司法》"）《公司章程》等有关规定，该辞任报告自送达董事会之 日起生效，其已按照公司相关规定做好交接工作。薛志伟先生辞任董事后将不再 关于非独立董事离任暨选举职工董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 宁波永新光学股份有限公司（以下简称"公司"）董事会于近日收到公司 非独立董事薛志伟先生的书面辞任报告。薛志伟先生因个人原因，辞去本公司董 事会非独立董事的职务，该辞任报告自送达董事会之日起生效。 2025 年 11 月 24 日，公司召开职工代表大会并做出决议，选举徐祖伟先 生为公司第八届董事会职工董事，任期自公司该次全体职工代表会议选举之日起 至公司第八届董事会任期届满之日止。 一、关于非独立董事离任情况 (一) 提前 ...

证券代码：603297 证券简称：永新光学 公告编号：2025-047 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 | 1、出席会议的股东和代理人人数 | 128 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 77,548,918 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | 69.9037 | | 份总数的比例（%） | | (四) 表决方式是否符合《公司法》及《公司章程》的规定，会议主持情况等。 本次股东会由公司董事会召集，由公司董事长曹其东先生主持，采用现场与 网络投票相结合的方式召开。本次会议的召集、召开和表决方式符合《公司法》 等法律法规和《公司章程》的有关规定。 (一) 股东会召开的时间：2025 年 11 月 24 日 (二) 股东会召开的地点：浙江省宁波高新区木槿路 169 号公司会议室 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： 宁波永新光学股份有 ...

国浩律师（上海）事务所 法律意见书 国浩律师（上海）事务所 Grandall Law Firm (Shanghai) 中国 上海 上海市静安区山西北路 99 号苏河湾中心 MT25-28 楼，200085 25-28/F, Suhe Centre, 99 North Shanxi Road, Jing'an District, Shanghai, China, 200085 电话/TEL: (8621) 5234-1668 传真/FAX: (8621) 5234-1670 关于宁波永新光学股份有限公司 一、 关于本次股东会召集、召开的程序 2025年第一次临时股东会的法律意见书 致：宁波永新光学股份有限公司 国浩律师（上海）事务所（以下简称"本所"）接受宁波永新光学股份有限 公司（以下简称"公司"）委托，指派本所律师出席公司 2025 年第一次临时股 东会（以下简称"本次股东会"）。本所律师根据《中华人民共和国证券法》（以 下简称"《证券法》"）、《中华人民共和国公司法》（以下简称"《公司法》"）、 《上市公司股东会规则》（以下简称"《股东会规则》"）等法律、法规、部门 规章和规范性文件以及《宁波永新光学股份 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：603297 证券简称：永新光学 公告编号：2025-049 宁波永新光学股份有限公司 第八届董事会第十四次会议决议公告 表决结果：同意 9 票；反对 0 票；弃权 0 票。 一、董事会会议召开情况 特此公告。 宁波永新光学股份有限公司（以下简称"公司"）于 2025 年 11 月 14 日以 电子邮件及专人送达方式发出了关于召开公司第八届董事会第十四次会议的通 知，本次会议于 2025 年 11 月 24 日以现场方式召开。本次会议应出席董事 9 名， 实际出席董事 9 名，公司高级管理人员列席会议，会议由董事长曹其东先生主持。 本次会议的召开符合《中华人民共和国公司法》（以下简称"《公司法》"）和 《公司章程》的有关规定，所作决议合法有效。 宁波永新光学股份有限公司董事会 二、董事会会议审议情况 2025 年 11 月 25 日 经过充分讨论，会议审议并通过了如下决议： 1、审议并通过《关于制定<公司舆情管理制度>的议案》 为提高公司应对各类舆情的能力，建立快速反应 ...

宁波永新光学股份有限公司 舆情管理制度 第一章 总则 第一条 为了提高宁波永新光学股份有限公司（以下简称"公司"）应对各 类舆情的能力，建立快速反应和应急处置机制，及时、妥善处理各类舆情对公司 股票、商业信誉及正常生产经营活动造成的影响，切实保护投资者合法权益，根 据《中华人民共和国公司法》《上海证券交易所股票上市规则》等法律法规、规 范性文件和《宁波永新光学股份有限公司章程》等有关规定，结合公司实际情况， 制定本制度。 第二条 本制度适用于公司及下属子（分）公司。 第三条 本制度所称舆情包括： （一）报刊、电视、网络等媒体对公司进行的负面报道或不实报道； （二）社会上存在的已经或将给公司造成不良影响的传言或信息； （三）可能或者已经影响社会公众投资者投资取向，造成公司股票及其衍生 品种交易价格异常波动的信息； （四）其他涉及公司信息披露且可能对公司股票及其衍生品种交易价格产生 重大影响的事件信息。 第四条 舆情信息的分类： （一）重大舆情：指传播范围较广，严重影响公司公众形象或正常经营活动， 使公司已经或可能遭受损失，已经或可能造成公司股票及其衍生品种交易价格变 动的负面舆情。 （二）一般舆情：指除重大舆情 ...